Eris Lifesciences Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
16 May 2024HDFC Mutual Fund
Reg29(2)
Acquisition Open Market 2,721,065
2.00%
— 7.13% No
6 May 2024UTI Mutual Fund alongwith PAC
Reg29(2)
Sale Others — 28,000
0.02%
4.98% No
6 May 2024UTI Mutual Fund alongwith PAC
Reg29(2)
Sale Others — 28,000
0.02%
4.98% No
13 Feb 2024UTI Mutual Fund alongwith PAC
Reg29(1)
Acquisition Others 74,875
0.05%
— 5.02% No
21 Dec 2023UTI Mutual Fund alongwith PAC
Reg29(2)
Sale Others — 140,000
0.10%
4.99% No
20 Dec 2023HDFC Mutual Fund
Reg29(1)
Acquisition Open Market 200,000
0.15%
— 5.13% No
8 Jul 2023Amit Indusbhushan Bakshi
Reg29(2)
Acquisition Others 2,800,000
2.06%
— 36.88% Yes
17 Apr 2023UTI Mutual Fund alongwith PAC
Reg29(2)
Acquisition Others 429,358
0.31%
— 7.08% No
20 May 2021UTI Mutual Fund
Reg29(1)
Acquisition Others 152,258
0.11%
— 5.06% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.